Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avidity Biosciences Inc
(NQ:
RNA
)
44.98
-0.51 (-1.12%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Avidity Biosciences Inc
< Previous
1
2
3
4
5
Next >
Avidity Biosciences Shares Gain On Encouraging Data From Early-Stage Myotonic Dystrophy Trial
December 14, 2022
Via
Benzinga
REV Group, Avidity Biosciences And Some Other Big Stocks Moving Higher On Wednesday
December 14, 2022
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
What's Going On With Avidity Biosciences Stock?
December 14, 2022
Avidity Biosciences Inc (NASDAQ: RNA) shares are trading higher Wednesday after the company announced positive data demonstrating the first-ever successful
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 14, 2022
Via
Benzinga
AiViva's Diverse Product Pipeline Could Have The Potential To Transform Unmet Medical Needs
November 21, 2022
AiViva BioPharma is a clinical-stage biotech company developing innovative and transformative treatments and products to address unmet medical needs for a wide array of diseases.
Via
Benzinga
Recap: Avidity Biosciences Q2 Earnings
August 09, 2022
Avidity Biosciences (NASDAQ:RNA) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
What 4 Analyst Ratings Have To Say About Avidity Biosciences
July 20, 2022
Avidity Biosciences (NASDAQ:RNA) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Chardan Initiates Coverage On These 'Intriguing Small-Cap Stories"
July 20, 2022
Via
Benzinga
Short Interest Sector Focus: Healthcare Sector
October 20, 2022
As of the close of business on Wednesday, 10/19, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...
Via
Benzinga
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 11, 2022
On Wednesday, 807 companies reached new 52-week lows.
Via
Benzinga
Nasdaq Turns Higher; Crude Oil Rises Over 2%
September 27, 2022
U.S. stocks pared some losses toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 27, 2022
Gainers
Via
Benzinga
Avidity Biosciences, Kronos Worldwide And Some Other Big Stocks Moving Lower On Tuesday
September 27, 2022
U.S. stocks traded lower, with the Dow Jones dropping around 180 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
US Stocks Turn Lower; Dow Dips 175 Points
September 27, 2022
U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 175 points on Tuesday.
Via
Benzinga
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
September 27, 2022
Gainers
Via
Benzinga
US Stocks Open Higher; Dow Surges 300 Points
September 27, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Tuesday.
Via
Benzinga
Highly Rated Avidity Biosciences Hammered After Side Effect Sidelines Study
September 27, 2022
The stock has a high IBD Digital rating, but plummeted on the news.
Via
Investor's Business Daily
FDA Slaps Clinical Hold On Avidity's Early-Stage Myotonic Dystrophy Trial
September 27, 2022
The FDA has placed a partial clinical hold on new participant enrollment in Avidity Biosciences Inc's (NASDAQ: RNA) Phase 1/2 MARINA trial of AOC 1001 in adults with myotonic dystrophy type 1 (DM1).
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 27, 2022
Gainers 9 Meters Biopharma (NASDAQ:NMTR) stock moved upwards by 22.8% to $0.25 during Tuesday's pre-market session. The company's market cap stands at $65.8 million.
Via
Benzinga
Short Interest Sector Focus: Healthcare Sector
September 26, 2022
As of the close of business on Friday, 9/23, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...
Via
Benzinga
7 Unknown Biotech Stocks That Could Rocket in 2023
September 23, 2022
Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline.
Via
InvestorPlace
Short Interest Sector Focus: Healthcare Sector
August 30, 2022
As of the close of business on Monday, 8/29, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022
July 20, 2022
Upgrades
Via
Benzinga
Avidity Biosciences Or Dyne Therapeutics - Read On Raymond James' Rating Skew
July 12, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
July 12, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
July 11, 2022
Gainers Novo Integrated Sciences (NASDAQ:NVOS) shares increased by 21.7% to $2.3 during Monday's after-market session. The market value of their outstanding shares is at $68.8 million.
Via
Benzinga
Avidity Biosciences Earnings Perspective: Return On Capital Employed
June 14, 2022
According to data from Benzinga Pro, during Q1, Avidity Biosciences's (NASDAQ:RNA) reported sales totaled $1.79 million. Despite a 11.17% increase in earnings, the company posted a loss of $34.23...
Via
Benzinga
Avidity Biosciences Earnings Perspective: Return On Capital Employed
March 07, 2022
Benzinga Pro data, Avidity Biosciences (NASDAQ:RNA) reported Q4 sales of $1.85 million. Earnings fell to a loss of $38.54 million, resulting in a 31.65% decrease from last...
Via
Benzinga
Avidity Biosciences: Q4 Earnings Insights
March 01, 2022
Avidity Biosciences (NASDAQ:RNA) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.